<?xml version='1.0' encoding='ISO-8859-1' ?>
<rss version="2.0">
	<channel>
		<title>TrialResults-center - acute coronary syndrome - Trials recently added</title>
		<link>http://www.trialresultscenter.org/</link>
		<description><![CDATA[TrialResults-center is a knowledge base allowing easy access to the clinical trials results]]></description>
		<language>fr</language>
		<copyright>Copyright 2004-2009 TrialResults-center team</copyright>
		<pubDate>09/02/2010 01:08:23</pubDate>
		<lastBuildDate>09/02/2010 01:08:23</lastBuildDate>
				
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - anticoagulant - All ACS (including AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m167.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - direct factor Xa inhibitors - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m345.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[B0661004 -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					Apixaban 2.5 or 5 mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - patients with a recent ACS 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m387.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - anticoagulant - All ACS (including AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m167.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - direct factor Xa inhibitors - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m345.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[APPRAISE 2 (CV185-068) -  apixaban vs placebo]]></title> 
				<description><![CDATA[New trials comparing
					apixaban 5mg twice daily <i>versus</i> placebo
					added in section
					acute coronary syndrome - antithrombotics - patients with a recent ACS 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m387.htm]]></link>	
				<pubDate>16/01/2010</pubDate>
			</item>
					
			<item>
				<title><![CDATA[PLATO -  ticagrelor + aspirin vs clopidogrel + aspirin]]></title> 
				<description><![CDATA[New trials comparing
					ticagrelor 90mg twice daily <i>versus</i> clopidogrel 75mg once daily
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>30/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[PLATO -  ticagrelor + aspirin vs clopidogrel + aspirin]]></title> 
				<description><![CDATA[New trials comparing
					ticagrelor 90mg twice daily <i>versus</i> clopidogrel 75mg once daily
					added in section
					acute coronary syndrome - antiplatelets drug - ACS (excluding AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m169.htm]]></link>	
				<pubDate>30/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[PLATO -  ticagrelor + aspirin vs clopidogrel + aspirin]]></title> 
				<description><![CDATA[New trials comparing
					ticagrelor 90mg twice daily <i>versus</i> clopidogrel 75mg once daily
					added in section
					acute coronary syndrome - antiplatelets drug - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m346.htm]]></link>	
				<pubDate>30/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[SEPIA-ACS1 TIMI 42 -  otamixaban vs unfractioned heparin]]></title> 
				<description><![CDATA[New trials comparing
					otamixaban 5 doses (0·08 mg/kg bolus followed by 0.035, 0.070, 0.105, 0.140, 0.175 mg/kg/h) <i>versus</i> Heparin+eptifibatide
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[SEPIA-ACS1 TIMI 42 -  otamixaban vs unfractioned heparin]]></title> 
				<description><![CDATA[New trials comparing
					otamixaban 5 doses (0·08 mg/kg bolus followed by 0.035, 0.070, 0.105, 0.140, 0.175 mg/kg/h) <i>versus</i> Heparin+eptifibatide
					added in section
					acute coronary syndrome - anticoagulant - All ACS (including AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m167.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[SEPIA-ACS1 TIMI 42 -  otamixaban vs unfractioned heparin]]></title> 
				<description><![CDATA[New trials comparing
					otamixaban 5 doses (0·08 mg/kg bolus followed by 0.035, 0.070, 0.105, 0.140, 0.175 mg/kg/h) <i>versus</i> Heparin+eptifibatide
					added in section
					acute coronary syndrome - direct factor Xa inhibitors - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m345.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[CURRENT OASIS 7 (clopidogrel) -  clopidogrel high loading dose vs clopidogrel standard dose]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[CURRENT OASIS 7 (clopidogrel) -  clopidogrel high loading dose vs clopidogrel standard dose]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antiplatelets drug - ACS (excluding AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m169.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[CURRENT OASIS 7 (clopidogrel) -  clopidogrel high loading dose vs clopidogrel standard dose]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antiplatelets drug - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m346.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[CURRENT - OASIS 7 (ASA) -  ASA high dose vs ASA low dose]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antithrombotics - all type of patient 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m24.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[CURRENT - OASIS 7 (ASA) -  ASA high dose vs ASA low dose]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antiplatelets drug - ACS (excluding AMI) 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m169.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
					
			<item>
				<title><![CDATA[CURRENT - OASIS 7 (ASA) -  ASA high dose vs ASA low dose]]></title> 
				<description><![CDATA[New trials comparing
					 <i>versus</i> 
					added in section
					acute coronary syndrome - antiplatelets drug - all type of patients 

					Go to trialys site to discover this new clinical trial and updated meta-analysis. ]]></description>
				<link><![CDATA[http://www.trialresultscenter.org/TRC_m346.htm]]></link>	
				<pubDate>26/08/2009</pubDate>
			</item>
			
	</channel>
</rss>
